Dow Jones

40,211.72

0.53%

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

XLRN

Acceleron Pharma (XLRN)

Acceleron Pharma Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:XLRN

<< Anterior 2 3 4 5 6 7 8 9 10 11 12 13 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
12/05/2014	06:00	Business Wire	Acceleron to Present at 2014 UBS Global Healthcare Conference	NASDAQ:XLRN	Acceleron Pharma Inc
08/05/2014	06:00	Business Wire	Acceleron Pharma to Host First Quarter 2014 Financial Results Conference Call and Webcast on May 15, 2014	NASDAQ:XLRN	Acceleron Pharma Inc
07/05/2014	16:42	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XLRN	Acceleron Pharma Inc
06/05/2014	15:08	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:XLRN	Acceleron Pharma Inc
02/05/2014	15:24	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:XLRN	Acceleron Pharma Inc
30/04/2014	16:25	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:XLRN	Acceleron Pharma Inc
23/04/2014	15:30	Business Wire	Acceleron & Celgene Announce Interim Clinical Data for Sotatercept Demonstrating Dose Dependent Increases in Hemoglobin in Pa...	NASDAQ:XLRN	Acceleron Pharma Inc
16/04/2014	15:22	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:XLRN	Acceleron Pharma Inc
11/04/2014	07:00	PR Newswire (US)	FDA Recommendations, Study Publications, Recognitions, Agreements, and Acquisitions - Analyst Notes on MannKind, Acceleron, S...	NASDAQ:XLRN	Acceleron Pharma Inc
02/04/2014	09:54	Dow Jones News	Celgene Agrees to Acquire 1.1 Million Acceleron Pharma Shares	NASDAQ:XLRN	Acceleron Pharma Inc
24/03/2014	06:30	Business Wire	Acceleron, Celgene & Collaborators Announce Two Publications in Nature Medicine Describing Sotatercept & ACE-536 Therapeutic ...	NASDAQ:XLRN	Acceleron Pharma Inc
21/03/2014	07:00	PR Newswire (US)	Earnings Release and Presentation Schedules, Nominations, and Financial Results - Analyst Notes on Five Prime Therapeutics, A...	NASDAQ:XLRN	Acceleron Pharma Inc
20/03/2014	06:30	Business Wire	Acceleron to Present at the 21st Annual Future Leaders in the Biotech Industry Conference	NASDAQ:XLRN	Acceleron Pharma Inc
17/03/2014	16:27	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:XLRN	Acceleron Pharma Inc
17/03/2014	15:30	Business Wire	Acceleron & Celgene Announce Interim Clinical Data for Sotatercept in Patients with End Stage Renal Disease on Hemodialysis a...	NASDAQ:XLRN	Acceleron Pharma Inc
07/03/2014	05:19	PR Newswire (US)	Financial Results Releases, Clinical Study Updates, Stock Summaries, and Strategic Agreements - Analyst Notes on Insmed, Medt...	NASDAQ:XLRN	Acceleron Pharma Inc
27/02/2014	06:00	Business Wire	Acceleron to Present at Cowen and Company 34th Annual Health Care Conference	NASDAQ:XLRN	Acceleron Pharma Inc
26/02/2014	06:00	Business Wire	Acceleron Pharma Reports Fourth Quarter and Year Ended 2013 Financial Results	NASDAQ:XLRN	Acceleron Pharma Inc
19/02/2014	06:00	Business Wire	Acceleron Pharma to Host Fourth Quarter and Year Ended 2013 Financial Results Conference Call and Webcast on February 26, 2014	NASDAQ:XLRN	Acceleron Pharma Inc
14/02/2014	15:35	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:XLRN	Acceleron Pharma Inc
14/02/2014	12:47	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:XLRN	Acceleron Pharma Inc
05/02/2014	06:00	Business Wire	Acceleron to Present at 2014 Leerink Global Healthcare Conference	NASDAQ:XLRN	Acceleron Pharma Inc
28/01/2014	15:30	Business Wire	Acceleron Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares	NASDAQ:XLRN	Acceleron Pharma Inc
22/01/2014	21:30	Business Wire	Acceleron Announces Pricing of Public Offering of Common Stock	NASDAQ:XLRN	Acceleron Pharma Inc
21/01/2014	05:30	Business Wire	Acceleron Commences Proposed Public Offering of Common Stock	NASDAQ:XLRN	Acceleron Pharma Inc
16/01/2014	17:50	Zacks	Pipeline Update from XenoPort - Analyst Blog	NASDAQ:XLRN	Acceleron Pharma Inc
14/01/2014	17:50	Zacks	Pipeline Update from BioDelivery Sciences - Analyst Blog	NASDAQ:XLRN	Acceleron Pharma Inc
09/01/2014	17:09	Business Wire	Acceleron Files Registration Statement for Proposed Public Offering of Common Stock	NASDAQ:XLRN	Acceleron Pharma Inc
20/12/2013	06:00	Business Wire	Acceleron Pharma to Be Added to Russell 2000® Index	NASDAQ:XLRN	Acceleron Pharma Inc
18/12/2013	06:00	Business Wire	Acceleron Earns $7 Million Milestone Payment for Celgene’s Initiation of Sotatercept Phase 2 Clinical Trial in Patients wit...	NASDAQ:XLRN	Acceleron Pharma Inc